A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
about
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasManagement of a delayed post-pancreatoduodenectomy haemorrhage using endovascular techniques.Does regional variation impact decision-making in the management and palliation of pancreatic head adenocarcinoma? Results from an international surveySarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinomaOutcome and costs of laparoscopic pancreaticoduodenectomy during the initial learning curve vs laparotomyNinety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality.Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy.The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection.Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective StudyEastern Canadian Gastrointestinal Cancer Consensus Conference 2016.Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis.Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyA 25-gene classifier predicts overall survival in resectable pancreatic cancer.Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma.Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.Neural network dose models for knowledge-based planning in pancreatic SBRT.Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China.
P2860
Q28075892-DDF268A9-63A2-4C68-88E7-645D39A54C74Q30278920-F3D8AE85-49D3-4F53-9F76-2E0DA82E31EAQ33671096-7BB307FF-3CF1-4EC5-8735-7A20C51FD888Q35528619-CCE5032D-B7CA-4410-9D06-D739959D7B8BQ35567665-69C0CC87-92CB-4880-8C19-FD94128AB0D0Q36249120-8CFE6BB4-5919-4D33-90F3-FFB01E81289FQ36252523-86730202-C798-4B3F-8E82-1AA8FA96045DQ36747432-EADF4CE4-C648-4747-84BE-9A64C15E121BQ36993625-30C50B52-92E7-4B46-AE4B-AC8F88B49B4CQ37204959-E9FB46C7-EF35-4F3D-9191-9E9E68D44589Q37524976-0F385712-E84D-4C57-BE43-B6E5E661209DQ38570657-01925E22-22B7-4A16-B6F7-12DF59C2FDF9Q38719146-00F277E9-E8B0-4C61-BB74-C1AEFC638642Q38927638-CA6E0AD9-0552-412C-A238-FD03FA136094Q39621435-4FC62401-C8FF-4100-A825-AF8C564DFBDDQ40281513-6024D602-E967-4A6D-9741-8CC7003767D2Q41545288-EA7F4A97-0D44-419B-A532-6602F3B57C07Q41711884-0B633B7F-45AF-47E6-A8C0-7C76FB4A18FFQ47198899-3B26C0F1-3D9D-4E67-8273-699F2AEE624DQ47330535-75090D6C-75EE-4BF1-A225-E11288630931Q51751748-32AA9CA6-28ED-48D9-9999-B64EA1B1474DQ51772050-C0E02E4E-2DA7-4328-90CD-64675D14D19BQ52469499-196D5377-E192-4E4D-8BBF-E100E126586FQ55262248-AE021333-D446-4C39-9D3B-F95B0F3BB66E
P2860
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@ast
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@en
type
label
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@ast
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@en
prefLabel
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@ast
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@en
P2093
P2860
P1476
A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
@en
P2093
Charles M Vollmer
Douglas Fraker
Jeffrey A Drebin
Jenna Gates
Mark P Callery
Russell Lewis
Tara S Kent
P2860
P356
10.1111/J.1477-2574.2012.00571.X
P577
2012-09-24T00:00:00Z